Risk Horizon
Live

Intelligence generated by AI from public regulatory sources. Not investment or regulatory advice. Verify before relying on any output.

StableMedium2026-08-02

CFTC grants Kraken Derivatives no-action relief on DCM dormancy

MarketsOtherGeneral RegulatoryCapital MarketsUnited StatesConf: Medium
Regulatory Event

CFTC DMO issued a time-limited no-action letter to Kraken Derivatives Exchange Inc. (formerly Small Exchange) regarding DCM dormancy procedures.

Analysis

The relief extends prior no-action treatment for Kraken's DCM following its rebranding from Small Exchange. It signals continued CFTC accommodation of crypto-affiliated derivatives venues navigating relaunch and product listing timelines.

Relevance

Relevant to firms operating or accessing US crypto-derivatives venues; indicates CFTC posture on venue continuity and dormancy compliance.

Required Action

Action Required

Track precedent for DCM dormancy relief and assess implications for market access and product listing timelines.

Justification

Entity-specific but signals CFTC approach to dormant DCMs and crypto-linked venue expansion.

Control Commentary

Note CFTC no-action relief for Kraken Derivatives Exchange on dormancy; review counterparty due diligence on DCM operational status; monitor conditions and expiry of no-action letter.

Source

CFTC Division of Market Oversight issued a time-limited no-action letter to Kraken Derivatives Exchange Inc., formerly Small Exchange Inc., addressing DCM dormancy procedures.

RH-2026-07-26-002